Newron Pharmaceuticals S.p.A. (FRA:NP5)
7.54
+0.07 (0.94%)
Last updated: Jul 31, 2025
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of €148.01 million as of August 1, 2025. Its market cap has decreased by -5.84% in one year.
Market Cap
148.01M
Enterprise Value
189.05M
Revenue
51.39M
Ranking
n/a
PE Ratio
9.34
Stock Price
€7.54
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 148.01M, a decrease of -23.76%. That is a compound annual growth rate of -1.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 148.01M | -20.02% |
Dec 30, 2024 | 185.06M | 94.99% |
Dec 29, 2023 | 94.91M | 239.07% |
Dec 30, 2022 | 27.99M | 0.21% |
Dec 30, 2021 | 27.93M | -20.96% |
Dec 30, 2020 | 35.34M | -66.13% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 292.08B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 153.20B |
Allianz SE | 132.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 79.52B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.53B |
Deutsche Bank Aktiengesellschaft | 55.70B |